Funding for this research was provided by:
Innovation and Technology Commission - Hong Kong (ITT/026/18GP, ITS/085/10, ITT/023/17GP, ITS/113/15FP)
Science, Technology and Innovation Commission of Shenzhen Municipality (JCYJ20170818113656988)
University Grants Committee of Hong Kong (DG17SC01, SBI16SC03)
Received: 19 October 2019
Accepted: 15 January 2020
First Online: 31 January 2020
Ethics approval and consent to participate
: Written informed consent was obtained from each patient who participated in this study. Subject recruitment and sample collection were approved by the institutional ethics review boards of Hong Kong University of Science and Technology, and National Center for Liver Cancer Research and the Eastern Hepatobiliary Surgery Hospital of Shanghai. Our research complies with the Declaration of Helsinki.
: Not applicable.
: A provisional US patent has been filed by PharmacoGenetics Ltd., a member of the Hong Kong University of Science and Technology entrepreneurship program.